It has indeed been shown that immunosuppressive CD33+ cells isolated from breast cancers patients are able to induce a stemness phenotype (associated with cancer cell chemoresistance) in the breast cancer cell line MCF-7 (64). The gene discussed is CD33; the disease is breast cancer.